Advertisement

Dysphagia

pp 1–6 | Cite as

Esophagogastroduodenoscopy and Esophageal Involvement in Patients with Pemphigus Vulgaris

  • Katharine A. OzekiEmail author
  • Thomas A. Zikos
  • John O. Clarke
  • Irene Sonu
Original Article
  • 23 Downloads

Abstract

Pemphigus vulgaris (PV) is a rare autoimmune blistering disease involving the skin and mucous membranes. The prevalence of esophageal involvement remains uncertain. The aim of our study was to determine the frequency of esophageal involvement in patients with PV. This is a single-center electronic database retrospective review of patients with a diagnosis of PV. Data abstracted included demographics, disease characteristics (biopsy results, symptoms, areas affected, treatments), and esophagogastroduodenoscopy (EGD) reports. Of the 111 patients that met eligibility criteria, only 22 (19.8%) underwent EGD. Demographic data were similar except those who underwent EGD were more likely to be female (77.3% vs. 51.7%, p = 0.05) and have hypertension (50.0% vs. 24.7%, p = 0.04). Esophageal symptoms were common in both groups; however, those experiencing dysphagia were more likely to undergo EGD (50.0% vs. 20.2%, p = 0.007). Those who underwent EGD had more refractory disease (≥ 3 treatment modalities: 100% vs. 58.4%, p < 0.001), but did not differ in areas affected. Of those who underwent EGD, only 4 (18.2%) had esophageal abnormalities either prior to PV diagnosis (1) or during a disease flare (3). Those having a flare were more likely to experience odynophagia (69.2%) or weight loss (61.5%), p = 0.02 and p = 0.05, respectively. While esophageal symptoms were common in our cohort of PV patients, a minority of patients underwent EGD, and the vast majority of those were unremarkable. This suggests that while esophageal symptoms are common in PV, permanent esophageal injury is more rare.

Keywords

Esophagogastroduodenoscopy Autoimmune Pemphigus vulgaris Dysphagia Esophageal symptoms Deglutition Deglutition disorders 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors have no conflict of interest to disclose.

References

  1. 1.
    Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007;11(3):462–81.  https://doi.org/10.1111/j.1582-4934.2007.00033.x.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Nishikawa T, Hashimoto T, Shimizu H, Ebihara T, Amagai M. Pemphigus: from immunofluorescence to molecular biology. J Dermatol Sci. 1996;12(1):1–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Bystryn JC, Rudolph JL. Pemphigus. Lancet. 2005;366(9479):61–73.  https://doi.org/10.1016/S0140-6736(05)66829-8.CrossRefPubMedGoogle Scholar
  4. 4.
    Mustafa MB, Porter SR, Smoller BR, Sitaru C. Oral mucosal manifestations of autoimmune skin diseases. Autoimmun Rev. 2015;14(10):930–51.  https://doi.org/10.1016/j.autrev.2015.06.005.CrossRefPubMedGoogle Scholar
  5. 5.
    Kavala M, Altintas S, Kocaturk E, Zindanci I, Can B, Ruhi C, Turkoglu Z. Ear, nose and throat involvement in patients with pemphigus vulgaris: correlation with severity, phenotype and disease activity. J Eur Acad Dermatol Venereol. 2011;25(11):1324–7.  https://doi.org/10.1111/j.1468-3083.2011.03981.x.CrossRefPubMedGoogle Scholar
  6. 6.
    Kavala M, Topaloglu Demir F, Zindanci I, Can B, Turkoglu Z, Zemheri E, Cam OH, Teksen A. Genital involvement in pemphigus vulgaris (PV): correlation with clinical and cervicovaginal Pap smear findings. J Am Acad Dermatol. 2015;73(4):655–9.  https://doi.org/10.1016/j.jaad.2015.06.057.CrossRefPubMedGoogle Scholar
  7. 7.
    Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol. 1996;132(2):203–12.CrossRefPubMedGoogle Scholar
  8. 8.
    Risser J, Lewis K, Weinstock MA. Mortality of bullous skin disorders from 1979 through 2002 in the United States. Arch Dermatol. 2009;145(9):1005–8.  https://doi.org/10.1001/archdermatol.2009.205.CrossRefPubMedGoogle Scholar
  9. 9.
    Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris–incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:a180.  https://doi.org/10.1136/bmj.a180.CrossRefPubMedGoogle Scholar
  10. 10.
    Galloro G, Mignogna M, de Werra C, Magno L, Diamantis G, Ruoppo E, Iovino P. The role of upper endoscopy in identifying oesophageal involvement in patients with oral pemphigus vulgaris. Dig Liver Dis. 2005;37(3):195–9.  https://doi.org/10.1016/j.dld.2004.10.005.CrossRefPubMedGoogle Scholar
  11. 11.
    Calka O, Akdeniz N, Tuncer I, Metin A, Cesur RS. Oesophageal involvement during attacks in pemphigus vulgaris patients. Clin Exp Dermatol. 2006;31(4):515–9.  https://doi.org/10.1111/j.1365-2230.2006.02132.x.CrossRefPubMedGoogle Scholar
  12. 12.
    Okamura A, Nakamura R, Yamagami J, Ishii K, Kawakubo H, Omori T, Takeuchi H, Amagai M, Kitagawa Y. Evaluation of pharyngo-oesophageal involvement in pemphigus vulgaris and its correlation with disease activity. Br J Dermatol. 2017;176(1):224–6.  https://doi.org/10.1111/bjd.14725.CrossRefPubMedGoogle Scholar
  13. 13.
    Rao PN, Samarth A, Aurangabadkar SJ, Pratap B, Lakshmi TS. Study of upper gastrointestinal tract involvement in pemphigus by esophago-gastro-duodenoscopy. Indian J Dermatol Venereol Leprol. 2006;72(6):421–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Mignogna MD, Lo Muzio L, Galloro G, Satriano RA, Ruocco V, Bucci E. Oral pemphigus: clinical significance of esophageal involvement: report of eight cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84(2):179–84.CrossRefPubMedGoogle Scholar
  15. 15.
    Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172–80.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Raque CJ, Stein KM, Samitz MH. Pemphigus vulagis involving the esophagus. Arch Dermatol. 1970;102(4):371–3.CrossRefPubMedGoogle Scholar
  17. 17.
    Kaplan RP, Touloukian J, Ahmed AR, Newcomer VD. Esophagitis dissecans superficialis associated with pemphigus vulgaris. J Am Acad Dermatol. 1981;4(6):682–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Palleschi GM, Cipollini EM, Lotti T. Development of oesophageal involvement in a subject with pemphigus vulgaris: a case report and review of the literature. J Eur Acad Dermatol Venereol. 2002;16(4):405–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Trattner A, Lurie R, Leiser A, David M, Hazaz B, Kadish U, Sandbank M. Esophageal involvement in pemphigus vulgaris: a clinical, histologic, and immunopathologic study. J Am Acad Dermatol. 1991;24(2 Pt 1):223–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of MedicineStanford University School of MedicineStanfordUSA
  2. 2.Division of Gastroenterology and Hepatology, Department of MedicineStanford University School of MedicineStanfordUSA

Personalised recommendations